Decade
3 known investors
Find your way into Decade
Decade develops targeted cancer therapies using AI and high-throughput data analysis to match treatments to individual patients' tumor molecular profiles.
Also known as Decade
Investors · 3
Company profile
researched Sep 2026Decade is a biotechnology company focused on oncology drug development. It applies artificial intelligence, high-throughput data generation and analysis, and cancer biology research to design targeted therapies aimed at the distinct molecular signatures found in individual patients' tumors.
▸Full profile — technology
Technology
The company's approach combines AI methods with high-throughput data and cancer biology expertise to identify and develop therapies directed at tumor-specific molecular features.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
In the news
▸Research sources · 8
primary sources listed
- Decadedecade.bio · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Decade do?
- Decade develops targeted cancer therapies matched to the molecular signature of an individual patient's tumor.
- Who are Decade's investors?
- Decade's investors include Tau Ventures, Benchmark, Greenoaks.